 Heterografts
"Heterografts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tissues, cells or organs transplanted between animals of different species.
| Descriptor ID |
D064593
|
| MeSH Number(s) |
A01.941.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heterografts".
Below are MeSH descriptors whose meaning is more specific than "Heterografts".
This graph shows the total number of publications written about "Heterografts" by people in this website by year, and whether "Heterografts" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 | | 2013 | 1 | 5 | 6 | | 2014 | 0 | 9 | 9 | | 2015 | 0 | 9 | 9 | | 2016 | 1 | 13 | 14 | | 2017 | 2 | 10 | 12 | | 2018 | 0 | 7 | 7 | | 2019 | 0 | 4 | 4 | | 2020 | 1 | 4 | 5 | | 2021 | 1 | 3 | 4 | | 2022 | 0 | 2 | 2 | | 2024 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Heterografts" by people in Profiles.
-
Adams AB, Blumberg EA, Gill JS, Katz E, Kawai T, Schold JD, Sykes M, Tector A, Sachs DH. Enhancing Kidney Transplantation and the Role of Xenografts: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2024 07; 84(1):94-101.
-
Randall J, Evans K, Watts B, Kosasih HJ, Smith CM, Earley EJ, Erickson SW, Jocoy EL, Bult CJ, Teicher BA, de Bock CE, Smith MA, Lock RB. In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts. Exp Hematol. 2024 Apr; 132:104176.
-
Kim HG, Huot JR, Pin F, Belcher DJ, Bonetto A, Nader GA. Metastatic or xenograft colorectal cancer models induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting in a tumor-type-dependent manner. J Appl Physiol (1985). 2022 12 01; 133(6):1273-1283.
-
Id Said B, Ailles L, Karamboulas C, Meens J, Huang SH, Xu W, Keshavarzi S, Bratman SV, Cho BCJ, Giuliani M, Hahn E, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A, Hosni A. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. JAMA Otolaryngol Head Neck Surg. 2022 04 01; 148(4):342-349.
-
Chan HHL, Haerle SK, Daly MJ, Zheng J, Philp L, Ferrari M, Douglas CM, Irish JC. An integrated augmented reality surgical navigation platform using multi-modality imaging for guidance. PLoS One. 2021; 16(4):e0250558.
-
Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, Dolan JT, Blatchford PJ, Freed BM, Torres RM, Davila E, Slansky JE, Pelanda R, Eckhardt SG, Messersmith WA, Diamond JR, Lieu CH, Verneris MR, Wang JH, Kiseljak-Vassiliades K, Pitts TM, Lang J. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Front Immunol. 2021; 12:607282.
-
Gamboa CM, Jara K, Pamarthy S, Liu L, Aiken R, Xiong Z, Danish S, Sabaawy HE. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening. STAR Protoc. 2021 03 19; 2(1):100345.
-
Zhang DG, Gong CC, Wu XJ, Ren X, Sedaka RS, Chen WC, Huo FC, Chen C, Du WQ, Pei DS. P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer. Signal Transduct Target Ther. 2021 02 05; 6(1):47.
-
Dwyer AR, Truong TH, Kerkvliet CP, Paul KV, Kabos P, Sartorius CA, Lange CA. Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer. Br J Cancer. 2021 01; 124(1):217-227.
-
Sherbenou DW, Su Y, Behrens CR, Aftab BT, Perez de Acha O, Murnane M, Bearrows SC, Hann BC, Wolf JL, Martin TG, Liu B. Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma. Clin Cancer Res. 2020 11 15; 26(22):6028-6038.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|